Navigation Links
Genomatix joins Illumina-Connect program
Date:1/28/2009

Munich, Germany and Ann Arbor, MI, USA, Jan 28 , 2009 Genomatix Software announced today that is has joined the Illumina-Connect program, linking them to the ongoing Illumina program and working with them to develop new tools and applications for Illumina-generated data.

Klaus May, Chief Business Officer for Genomatix Software in Munich, Germany commented: "As the industry's only provider of a complete NGS data analysis capability, we are extremely pleased to be part of Illumina's effort. The majority of our current customer base is generating their NGS data on Illumina machines, and as such we are very familiar with them". Peter Grant, Chief Executive Officer for Genomatix Software in Ann Arbor, Michigan, further commented "Working with Illumina generated NGS data has helped us greatly in our ongoing effort to refine and further expand our analysis capabilities in this very demanding market. Being a part of the Illumina-Connect program should help us to better focus those efforts as well as help us keep up with the rapidly expanding portfolio of Illumina NGS applications".

Besides the well established Genomatix microarray analysis pipeline which works with output from the Illumina BeadChip platform Genomatix delivers a complete solution for the analysis of Next Generation Sequencing (NGS) data. This combined software/hardware platform consists of two units: the Genomatix Mining Station (GMS) and the Genomatix Genome Analyzer (GGA).

The GMS is based on a proprietary genomic pattern recognition paradigm, or GenomeThesaurus, which allows for input of raw sequence reads plus optional quality files from any deep sequencing hardware, especially the Illumina Genome Analyzer. It provides ultra fast mapping of sequences of any length (starting from 8bp) with no practical limits on the number of point mutations and/or insertions and deletions that can be taken into account during the mapping process. Depending on the nature of the experiment, the GMS can provide SNP detection and genotyping, copy number analysis, and small RNA analysis. For ChIPseq data, the GMS delivers clustering and peak finding, and performs automated binding pattern identification. For RNAseq experiments, normalized expression values are calculated at the exon and transcript level. A special GenomeThesaurus is also provided for potential splice junctions, which allows for splice junction analysis and identification of new transcriptional units.For genomic re-sequencing and newly sequenced genomes, a de novo assembly will be provided.

The GGA delivers downstream software tools and databases for the deep biological analysis of genomic position data coming from the GMS or any other technology. It allows for easy integration and visualization in the terabytes of background annotation of the ElDorado genome database. GGA extensively annotates genomic coordinates and surrounding regions. Clustering and peak finding, analysis for phylogenetic conservation, large scale correlation analysis with annotated genomic elements, meta-analysis of data correlation between different experiments, pathway mining for groups of identified genes, transcription factor binding site (TFBS) analysis ( identification, over-representation, binding partner analysis, framework identification, phylogenetic conservation, regulatory SNP effects) and much more are all processes carried out on the GGA.


'/>"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Related biology news :

1. Pfizer inks global license to Genomatix Software and databases
2. NIA uses Genomatix in stem cell research, suggests novel transcription factors for stemness
3. GEN joins Charles Darwin 2009 celebration
4. FSU joins coalition working to improve nations power grid
5. Len Hunt Joins Gallup Consulting Group
6. Luxembourg joins EMBL
7. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
8. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
9. Nutritional supplementation program helps prevent weight loss among children in African country
10. CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services
11. New research program for energy innovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology: